×

Inovalon to Present at the William Blair 35th Annual Growth Stock Conference on June 9, 2015

BOWIE, Md., May 26, 2015 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced cloud-based analytics and data-driven intervention platforms to the healthcare industry, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board, along with Thomas Kloster, chief financial officer and Dan Rizzo, chief innovation officer, will present at the William Blair 35th Annual Growth Stock Conference at 12:50 p.m. CDT on Tuesday, June 9, 2015. The conference takes place June 9–11, at the Four Seasons Hotel in Chicago.

About Inovalon

Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms, and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Providing technology that supports hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's cloud-based analytical and data-driven intervention platforms are informed by data pertaining to more than 763,000 physicians, 257,000 clinical facilities, and more than 121 million Americans providing a powerful solution suite that drives high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. For more information, visit www.inovalon.com.

CONTACT: Inovalon Kim E. Collins (Investors) 4321 Collington Road Bowie, Maryland 20716 Phone: 301-809-4000 x1473 kcollins@inovalon.com Greenough on Behalf of Inovalon Andrea LePain Phone: 617-275-6526 alepain@greenough.com

Source:Inovalon Holdings, Inc.